"The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended the marketing of selexipag (Uptravi, Actelion Registration Ltd) for the treatment of adults with pulmonary arterial hypertension (PAH)./"...
Adalat CC (nifedipine) is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.
DOSAGE AND ADMINISTRATION
Dosage should be adjusted according to each patient's needs. It is recommended that Adalat CC (nifedipine) be administered orally once daily on an empty stomach. Adalat CC is an extended release dosage form and tablets should be swallowed whole, not bitten or divided. In general, titration should proceed over a 7-14 day period starting with 30 mg once daily. Upward titration should be based on therapeutic efficacy and safety. The usual maintenance dose is 30 mg to 60 mg once daily. Titration to doses above 90 mg daily is not recommended.
If discontinuation of Adalat CC (nifedipine) is necessary, sound clinical practice suggests that the dosage should be decreased gradually with close physician supervision.
Care should be taken when dispensing Adalat CC (nifedipine) to assure that the extended release dosage form has been prescribed.
Adalat CC (nifedipine) extended release tablets are supplied as 30 mg, 60 mg, and 90 mg round film coated tablets. The different strengths can be identified as follows
|30 mg||Pink||30 on one side and ADALAT CC on the other side|
|60 mg||Salmon||60 on one side and ADALAT CC on the other side|
|90 mg||Dark Red||90 on one side and ADALAT CC on the other side|
AdalatCC Tablets are supplied in:
|Bottles of 100||30 mg||0085-1701-02|
|Unit Dose Packages of 100||30 mg||0085-1701-03|
|Bottles of 1000||30 mg||0085-1701-01|
The tablets should be protected from light and moisture and stored below 86°F (30°C). Dispense in tight, light-resistant containers.
Manufactured by: Bayer HealthCare Pharmaceuticals Inc. Made in Germany. Distributed by: Schering Corporation, a subsidiary of Merck & Co., Inc, Whitehouse Station, NJ 08889, USA. Revised: 8/10This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 4/14/2011
Additional Adalat CC Information
Adalat CC - User Reviews
Adalat CC User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get tips on handling your hypertension.